Strella Biotechnology, Inc. — Form D
Strella Biotechnology, Inc. of Seattle, WA, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-10. The offering totals $5.6M, of which $5.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-09-10
- Form: D
- Accession: 0001810011-24-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.6M
- Amount sold: $5.6M
- Minimum investment: $1
- Investors: 17
- Date of first sale: 2024-02-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-523610
Issuer
- Name: Strella Biotechnology, Inc.
- CIK: 0001810011
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 119 Pine Street Ste. 305, Seattle, WA, 98101
- Phone: 703-909-4543
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Eric Linn | Director | Seattle, WA |
| Nolan Paul | Director | Seattle, WA |
| Katherine Sizov | Director | Seattle, WA |
| Katherine Sizov | Executive Officer | Seattle, WA |
| Katherine Sizov | Promoter | Seattle, WA |
| Brett Topche | Director | Philadelphia, PA |
| Jacob Jordan | Director | Philadelphia, PA |
| Jacob Jordan | Executive Officer | Philadelphia, PA |
| Jacob Jordan | Promoter | Philadelphia, PA |
Other filings by this issuer (1)
More